🔎 Trials Near Me

Home › Kanser sa Suso › Delaware › Newark

Pag-aaral pangklinika para sa Kanser sa Suso sa Newark, DE

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Newark. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Nagre-recruitPhase 3
  • Medical Oncology Hematology Consultants, P.A., Newark
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2
  • Medical Oncology Hematology Consultants, Newark
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Nagre-recruitPhase 3
  • Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07060807

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • at 1 pa
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Nagre-recruitPhase 2/3
  • Medical Oncology Hematology Consultants, PA, Newark
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06926868

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care - Union Hospital, Elkton · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Newark
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Nagre-recruitObservasyonal na pag-aaral
  • Medical Oncology and Hematology Consultants, Newark
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2025 · NCT03053193

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Newark

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.